Quarterly Results

  • Company Name :
Jubilant Pharmova Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 530019
  • NSE Symbol:
  • JUBLPHARMA
  • P/E(TTM):
  • 341.05
  • ISIN Demat:
  • INE700A01033
  • Div & Yield%:
  • 0.47
  • EPS(TTM):
  • 3.09
  • Book Value(₹):
  • 144.30
  • Market Cap(₹Cr.):
  • 16,787.83
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 193.40 162.60 162.70
Excise Duty 0.00 0.00 0.00
Net Sales 193.40 162.60 162.70
Other Operating Income 2.60 3.10 4.00
Other Income 18.40 43.80 19.50
Total Income 214.40 209.50 186.20
Total Expenditure 185.00 171.80 176.70
PBIDT 29.40 37.70 9.50
Interest 7.40 7.80 7.60
PBDT 22.00 29.90 1.90
Depreciation 13.30 13.30 13.10
Tax 6.30 5.30 0.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -2.90 0.80 -1.00
Reported Profit After Tax 5.30 10.50 -10.20
Extra-ordinary Items 0.00 0.00 -11.20
Adjusted Profit After Extra-ordinary item 5.30 10.50 1.00
EPS (Unit Curr.) 0.33 0.66 -0.64
EPS (Adj) (Unit Curr.) 0.33 0.66 -0.64
Calculated EPS (Unit Curr.) 0.33 0.66 -0.64
Calculated EPS (Adj) (Unit Curr.) 0.33 0.66 -0.64
Calculated EPS (Ann.) (Unit Curr.) 1.33 2.64 -2.57
Calculated EPS (Adj) (Ann.) (Unit Curr.) 1.33 2.64 -2.57
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 15.90 15.90 15.90
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 15.20 23.19 5.84
PBDTM(%) 11.38 18.39 1.17
PATM(%) 2.74 6.46 -6.27